NCT02630654

Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs

Exploratory, Non-Interventional Study For Evaluating The Diagnostic, Prognostic And Response-Predictive Value Of A Multi Biomarker Approach In Metastatic GEP NETs

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 404 (actual)
• Sponsor: Ipsen · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This exploratory study aims to evaluate the diagnostic, prognostic and response predictive value of a multi biomarker strategy in patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs) originating from the midgut or pancreas. Using a recently developed methodology enabling the evaluation of 92 concomitant cancer biomarkers will provide an interesting approach to solve this question (Lundberg et al 2011).

Conditions

• Gastroenteropancreatic Neuroendocrine Tumors

Interventions

Type	Name	Description
OTHER	This is a non-interventional study. Patients will be treated with any intervention deemed appropriate by the patient's physician.

Timeline

• Start date: 2014-03-24
• Primary completion: 2021-11-09
• Completion: 2021-11-09
• First posted: 2015-12-15
• Last updated: 2021-12-07

Locations

25 sites across 7 countries: Denmark, Estonia, Finland, Latvia, Lithuania, Norway, Sweden